PMC:7601109 / 95199-95567 JSONTXT

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T199","span":{"begin":202,"end":205},"obj":"Body_part"},{"id":"T200","span":{"begin":341,"end":344},"obj":"Body_part"}],"attributes":[{"id":"A199","pred":"uberon_id","subj":"T199","obj":"http://purl.obolibrary.org/obo/UBERON_0000978"},{"id":"A200","pred":"uberon_id","subj":"T200","obj":"http://purl.obolibrary.org/obo/UBERON_0000978"}],"text":"78.5 ± 7.5 years, N = 199, N males = 99, N females = 95) EG1 and EG2: pRJ (1.2 and 4.8 g/d), respectivelyCG: placebo Handgrip strength, six-minute walk test, timed up and go test, and standing on one leg with eyes closed. pRJ had no significant effect on handgrip strength, six-minute walk test, timed up and go test, and standing on one leg with eyes closed. [59]"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T844","span":{"begin":202,"end":205},"obj":"Body_part"},{"id":"T845","span":{"begin":211,"end":215},"obj":"Body_part"},{"id":"T846","span":{"begin":341,"end":344},"obj":"Body_part"},{"id":"T847","span":{"begin":350,"end":354},"obj":"Body_part"}],"attributes":[{"id":"A844","pred":"fma_id","subj":"T844","obj":"http://purl.org/sig/ont/fma/fma24979"},{"id":"A845","pred":"fma_id","subj":"T845","obj":"http://purl.org/sig/ont/fma/fma54448"},{"id":"A846","pred":"fma_id","subj":"T846","obj":"http://purl.org/sig/ont/fma/fma24979"},{"id":"A847","pred":"fma_id","subj":"T847","obj":"http://purl.org/sig/ont/fma/fma54448"}],"text":"78.5 ± 7.5 years, N = 199, N males = 99, N females = 95) EG1 and EG2: pRJ (1.2 and 4.8 g/d), respectivelyCG: placebo Handgrip strength, six-minute walk test, timed up and go test, and standing on one leg with eyes closed. pRJ had no significant effect on handgrip strength, six-minute walk test, timed up and go test, and standing on one leg with eyes closed. [59]"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1695","span":{"begin":29,"end":34},"obj":"http://purl.obolibrary.org/obo/UBERON_0003101"},{"id":"T1696","span":{"begin":29,"end":34},"obj":"http://www.ebi.ac.uk/efo/EFO_0000970"},{"id":"T1697","span":{"begin":43,"end":50},"obj":"http://purl.obolibrary.org/obo/UBERON_0003100"},{"id":"T1698","span":{"begin":154,"end":158},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T1699","span":{"begin":176,"end":180},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T1700","span":{"begin":202,"end":205},"obj":"http://www.ebi.ac.uk/efo/EFO_0001411"},{"id":"T1701","span":{"begin":211,"end":215},"obj":"http://www.ebi.ac.uk/efo/EFO_0000827"},{"id":"T1702","span":{"begin":293,"end":297},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T1703","span":{"begin":315,"end":319},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T1704","span":{"begin":341,"end":344},"obj":"http://www.ebi.ac.uk/efo/EFO_0001411"},{"id":"T1705","span":{"begin":350,"end":354},"obj":"http://www.ebi.ac.uk/efo/EFO_0000827"}],"text":"78.5 ± 7.5 years, N = 199, N males = 99, N females = 95) EG1 and EG2: pRJ (1.2 and 4.8 g/d), respectivelyCG: placebo Handgrip strength, six-minute walk test, timed up and go test, and standing on one leg with eyes closed. pRJ had no significant effect on handgrip strength, six-minute walk test, timed up and go test, and standing on one leg with eyes closed. [59]"}

{"project":"LitCovid-sentences","denotations":[{"id":"T596","span":{"begin":0,"end":368},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"78.5 ± 7.5 years, N = 199, N males = 99, N females = 95) EG1 and EG2: pRJ (1.2 and 4.8 g/d), respectivelyCG: placebo Handgrip strength, six-minute walk test, timed up and go test, and standing on one leg with eyes closed. pRJ had no significant effect on handgrip strength, six-minute walk test, timed up and go test, and standing on one leg with eyes closed. [59]"}

{"project":"LitCovid-PubTator","denotations":[{"id":"2806","span":{"begin":58,"end":61},"obj":"Gene"}],"attributes":[{"id":"A2806","pred":"tao:has_database_id","subj":"2806","obj":"Gene:305391"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"78.5 ± 7.5 years, N = 199, N males = 99, N females = 95) EG1 and EG2: pRJ (1.2 and 4.8 g/d), respectivelyCG: placebo Handgrip strength, six-minute walk test, timed up and go test, and standing on one leg with eyes closed. pRJ had no significant effect on handgrip strength, six-minute walk test, timed up and go test, and standing on one leg with eyes closed. [59]"}